drugset / Trial / NCT00002412
A Study of MKC-442 in Combination With Other Anti-HIV Drugs
Double-blindTreatment
Summary
The purpose of this study is to see if it is safe and effective to give MKC-442 plus stavudine (d4T) plus didanosine (ddI) plus hydroxyurea.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Emivirine | Small molecule | — | — |
| Background | Didanosine | Small molecule | — | — |
| Background | Hydroxyurea | Other / unclassified | — | — |
| Background | Stavudine | Other / unclassified | — | — |